Filing Details
- Accession Number:
- 0001144204-10-018570
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-04-05 13:00:00
- Reporting Period:
- 2010-04-01
- Filing Date:
- 2010-04-05
- Accepted Time:
- 2010-04-05 17:51:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1318641 | Cleveland Biolabs Inc | CBLI | Services-Commercial Physical & Biological Research (8731) | 200077155 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1370084 | Yakov Kogan | 73 High Street Buffalo NY 14203 | Coo, Secretary | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-04-01 | 100 | $3.51 | 673,100 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-04-01 | 200 | $3.51 | 672,900 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-04-01 | 100 | $3.50 | 672,800 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-04-01 | 100 | $3.50 | 672,700 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-04-01 | 100 | $3.52 | 672,600 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-04-01 | 200 | $3.51 | 672,400 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-04-01 | 200 | $3.51 | 672,200 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-04-01 | 200 | $3.51 | 672,000 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-04-01 | 100 | $3.51 | 671,900 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-04-01 | 100 | $3.52 | 671,800 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-04-01 | 400 | $3.52 | 671,400 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-04-01 | 100 | $3.52 | 671,300 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-04-01 | 400 | $3.52 | 670,900 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-04-01 | 100 | $3.52 | 670,800 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-04-01 | 263 | $3.52 | 670,537 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-04-01 | 400 | $3.52 | 670,137 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-04-01 | 600 | $3.52 | 669,537 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-04-01 | 100 | $3.51 | 669,437 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-04-01 | 200 | $3.52 | 669,237 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-04-01 | 1,700 | $3.51 | 667,537 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-04-01 | 37 | $3.51 | 667,500 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-04-01 | 300 | $3.51 | 667,200 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Options (Right to Buy) | $8.36 | 2007-04-06 | 2017-04-05 | 37,500 | 37,500 | Direct |
Common Stock | Employee Stock Options (Right to Buy) | $4.00 | 2008-02-04 | 2018-02-03 | 137,250 | 174,750 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2017-04-05 | 37,500 | 37,500 | Direct |
2018-02-03 | 137,250 | 174,750 | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and represent approximately 0.8% of the reporting person's 715,200 shares held prior to adoption of the plan. The maximum sales subject to the plan in its entirety represent approximately 10.1% of the reporting person's shares held prior to adoption of the plan.